Page 7 - Inspiremd Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

InspireMD (NYSE:NSPR) Posts Earnings Results, Beats Expectations By $0 04 EPS

InspireMD (NYSE:NSPR – Get Free Report) released its earnings results on Wednesday. The company reported ($0.16) EPS for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.04, MarketWatch Earnings reports. InspireMD had a negative net margin of 320.97% and a negative return on equity of 55.71%. The business had revenue of $1.76 million for […]

United statesAsia pacificMarshall waceNorthern trust corpRenaissance technologiesInspiremd incNantahala capital managementGet free reportMarketwatch earningsTrust corpCapital managementLatin americaMiddle eastPrime delivery system

Head-To-Head Analysis: NeuroOne Medical Technologies (NASDAQ:NMTC) vs InspireMD (NYSE:NSPR)

Head-To-Head Analysis: NeuroOne Medical Technologies (NASDAQ:NMTC) vs InspireMD (NYSE:NSPR)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Eden prairieUnited statesTel aviv yafoTel avivAsia pacificInspiremd incNeuroone medical technologies corporationNeuroone medical technologiesGet free reportOne medical technologiesGiven neuroone medical technologieOne medical technologies corporationLatin americaMiddle eastPrime delivery systemNeuroone medical technologies daily

StockNews com Initiates Coverage on InspireMD (NYSE:NSPR)

StockNews.com began coverage on shares of InspireMD (NYSE:NSPR – Get Free Report) in a research report issued on Sunday. The brokerage set a “sell” rating on the stock. Separately, Piper Sandler boosted their price objective on shares of InspireMD from $3.50 to $4.50 and gave the stock an “overweight” rating in a research report on […]

United statesPiper sandlerAsia pacificGarys roubinMarshall waceInspiremd incSecurities exchange commissionRenaissance technologiesNottingham advisors incPura vida investmentsGet free reportDirector garyExchange commissionCapital investment managementVida investmentsLatin america

StockNews com Begins Coverage on InspireMD (NYSE:NSPR)

StockNews.com began coverage on shares of InspireMD (NYSE:NSPR – Free Report) in a research report report published on Saturday. The firm issued a sell rating on the stock. Separately, Piper Sandler lifted their price target on InspireMD from $3.50 to $4.50 and gave the company an overweight rating in a research report on Thursday, November […]

United statesAsia pacificPiper sandlerGarys roubinInspiremd incPura vida investmentsMarshall waceNottingham advisors incAvestar capitalFree reportGet free reportDirector garyCapital investment managementVida investmentsLatin americaMiddle east

InspireMD (NSPR) Receives CE Mark Recertification Under EU s New Medical Device Regulation (MDR) Regulatory Framework

InspireMD (NSPR) Receives CE Mark Recertification Under EU s New Medical Device Regulation (MDR) Regulatory Framework
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Marvin slosmanEuropean unionInspiremd incEmbolic prevention carotid stent systemMedical device regulationPremarket approval application